Compare BioNano Genomics Inc (BNGO) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Global X Lithium & Battery Tech ETF — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Global X Lithium & Battery Tech ETF trades at $75.23. The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | LIT | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $4.92 | $91.62 |
52-Week Low | $1.06 | $44.96 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
LIT trades at $75.60, up 1.15% with a bullish technical signal from moving averages and ADX, though RSI indicates overbought conditions. Recent news highlights strong EV sales growth and lithium demand catalysts, but key financial ratios are unavailable. The stock shows tight support at $74 and resistance at $75.
Outlook is positive due to EV and energy storage momentum, but risks include overbought technicals and reliance on lithium market cycles. Investment opportunity hinges on sustained demand growth, while volatility from commodity prices and competition poses challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
